Yes — Steadyway, and it knows Rybelsus is a tablet. Pick it during setup and the app stops talking about injections: no site rotation, no fridge clock, no pen supply. What is left is the part that still matters.
| Doses | 3, 7 and 14 mg |
|---|---|
| Taken as | Daily tablet, semaglutide |
| Licensed for | Type 2 diabetes (UK, EU, US) |
| Out of the fridge | Not refrigerated |
| Missed a dose | Skip it and take the next one tomorrow at the usual time. Do not take two tablets in a day to catch up. |
Does a GLP-1 tracker even apply to a tablet?
The delivery is different; the problem is not. There is still a daily schedule to keep, a titration through 3, 7 and 14 mg to remember, side effects that arrive and fade, and a weight trend that only means anything read over months. Those are the four things this app is for, and none of them is about needles.
Weight, read as a trend
A smoothed line inside a seven-day range band, with your rate of loss and where it puts your goal as the headline rather than a static gap. Raw daily dots are there if you want them, off by default — a bad morning on the scale is usually water, and a chart that leads with it turns an ordinary week into a bad one.
A reminder you place yourself
Rybelsus has strict rules about when in the day it is taken and what can follow it, and most people settle on the moment they wake. The app will remind you at whatever time you choose and will not lecture you about the rest — the timing instructions are on your leaflet, they are more specific than any app should paraphrase, and that specificity is exactly why the reminder earns its place.
If you move to an injection later
Plenty of people start on Rybelsus and change. Switch the medication in the app and the schedule, the ladder and the route follow it — site rotation appears, the fridge clock starts. Your weight history carries across untouched, because it belongs to you rather than to a drug.
